rituximab

by Amy Maxmen Very long article that speaks about Dr Jose Montoya, Dr Anthony Komaroff, Dr Leonard Jason, the Rituximab trial, Dr Derya Unutmaz, the NIH program, Dr Ron Davis and David Tuller https://www.nature.com/articles/d41586-017-08965-0?WT.feed_name=subjects_biotechnology Edit: Amy...

RME Sverige Published on Dec 19, 2017 Geraldine (Jo) Cambridge, PhD, Dep. Medicine, University College, London on B-cell depletion with Rituximab.

Following the news of the null result of the Norwegian Phase III trial, and interest in how this impacts the planned UK trial, I thought it might be useful to open a thread for this. The microsite for this UK rituximab trial and associated B-cell research is on Invest in ME Research Centre of...

Reflecting, in part, on the impact of the news of the Rituximab null result. https://tipsforme.wordpress.com/2017/11/24/attacked-by-hope/

Terrible news from Marky90 at PR: http://forums.phoenixrising.me/index.php?threads/rituximab-phase-iii-negative-result.56244/

I'm amazed I never heard of this! It was uploaded a year ago and has had only 1,500 views. Maria is my hero(ine)! She's the reason we got a rituximab trial, IMO. She's a previously bedbound medical doctor who recovered from her ME/CFS following rtx treatment in a pilot study by Fluge and...

Anomalous microbiome and metabolic profiling in ME/CFS-patients Prof Maureen Hanson, Cornell University, USA From 1:10:47 ME/CFS and the immune system. Where are we now? Geraldine (Jo) Cambridge, PhD, Dep. Medicine, University College, London From 5:33

Rituximab (RituxME) Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series Øystein Fluge and Olav Mella BMC Neurology 2009 Link to article Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in...